0

Urine D-arabinitol/L-arabinitol Ratio in Diagnosing Candida Infection in Patients With Haematological Malignancy and HIV Infection

Damon P Eisen, Paul B Bartley, William Hope, Gudrun Sigmundsdottir, Christina Pehrson, Lennart Larsson, Bertil Christensson

Diagn Microbiol Infect Dis. 2002 Jan;42(1):39-42.

PMID: 11821170

Abstract:

Adult patients with hematologic malignancies along with HIV infected patients were prospectively studied to determine the performance of urine D-arabinitol/L-arabinitol (DA/LA) ratio in diagnosing invasive candidiasis. Ten evaluable febrile neutropenic patients had proven invasive candidiasis and elevated DA/LA ratios were found in 5. Invasive candidiasis with normal DA/LA ratios was most frequently due to Candida krusei infection. This Candida species is a non-producer of arabinitol. Only 4 of 81 febrile neutropenic patients given either antifungal prophylaxis or empiric antifungal treatment had elevated DA/LA ratios. Only 1 of 15 HIV positive patients with either oropharyngeal or esophageal candidiasis had elevated DA/LA ratios. Widespread use of fluconazole prophylaxis in bone marrow transplantation patients at the study hospital has led to an increased prevalence of C. krusei infection. This is the likely reason for the low sensitivity of the test in proven and suspected invasive Candida infections reported here.

Chemicals Related in the Paper:

Catalog Number Product Name Structure CAS Number Price
AP7643756-A L-Arabinitol L-Arabinitol 7643-75-6 Price
qrcode